Clinical Trial Update: Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus Erythematosus [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study evaluating umbilical cord-derived mesenchymal stem cell transplantation for active and refractory systemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Systemic Lupus Erythematosus | Phase 1, Phase 2 | Status: UNKNOWN